UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
Immune analysis of the HBsAg seroclearance response terminating chronic HBV
Immune analysis of the HBsAg seroclearance response terminating chronic HBV is a funding opportunity from UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, up to 807001, closing October 31, 2029.
Oct 31, 2029
(1188d left)Overview
PROJECT SUMMARY Chronic infection with hepatitis B virus (HBV) is a major global problem affecting an estimated 300 million people. HBV-induced immune-mediated progressive liver injury and primary liver cancer led to a WHO-estimated 820,000 deaths in 2019. While clearance of the HBV surface antigen (HBsAg) defines…